Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)
Clinical trial NCT01324440 · COMPLETED
Trial details
- NCT number
- NCT01324440
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.